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Receipt of an abnormal cervical smear result often generates fear and confusion and can have a negative impact on a woman’s well-
being. Most previous studies have focussed on high-grade abnormal smears. This study describes the psychological and psychosocial
effects, on women, of having received a low-grade abnormal smear result. Over 3500 women recruited to TOMBOLA (Trial Of
Management of Borderline and Other Low-grade Abnormal smears) participated in this study. Anxiety was assessed using the
Hospital Anxiety and Depression Scale (HADS) at recruitment. Socio-demographic and lifestyle factors, locus of control and factors
associated with the psychosocial impact of the abnormal smear result were also assessed. Women reported anxiety levels consistent
with those found in previous studies of women with high-grade smear results. Women at highest risk of anxiety were younger, had
children, were current smokers, or had the highest levels of physical activity. Interventions that focus particularly on women’s
understanding of smear results and pre-cancer, and/or directly address their fears about cancer, treatment and fertility might provide
the greatest opportunity to reduce the adverse psychosocial impact of receiving a low-grade abnormal cervical smear result.
British Journal of Cancer (2006) 94, 1253–1262. doi:10.1038/sj.bjc.6603086 www.bjcancer.com
Published online 4 April 2006
& 2006 Cancer Research UK
Keywords: cervical intraepithelial neoplasia; mass screening; psychological factors; anxiety; questionnaires
                                               
The United Kingdom NHS Cervical Screening Programmes (CSPs)
have reduced the incidence of, and mortality from, cervical cancer
(Quinn et al, 1999; Sasieni and Adams, 1999). However, the
screening test has a high degree of sensitivity, resulting, each year,
in over 250000 cervical smears showing abnormalities (NHS
Cervical Screening Programmes, 2003; NHS Scotland, Information
and Statistics Division, 2004). For women, receipt of an abnormal
smear test result frequently leads to heightened levels of anxiety
(Bell et al, 1995; Gath et al, 1995; Maissi et al, 2004). Women who
have received an abnormal smear result have reported frequent
worries and feeling worse about their body (Lerman et al, 1991;
Wardle et al, 1995). Often an abnormal smear result leads to a fear
on the part of the woman that she has cancer (Doherty et al, 1991;
Lerman et al, 1991; Somerset and Peters, 1998) and to feelings of
self-blame, sexual guilt and concerns about infertility (McDonald
et al, 1989; Quilliam, 1990; Kavanagh and Broom, 1997).
The overwhelming majority of abnormal smears detected each
year are low-grade (i.e. borderline nuclear abnormalities (BNA) or
mild dyskaryosis). Most previous research on the psychosocial
impact of an abnormal smear has focussed on women with high-
grade abnormal smears (i.e. those showing moderate or severe
dyskaryosis) and has tended to recruit women attending for a
colposcopic examination, making it difficult to separate the
psychosocial sequelae of the smear test result itself from the
well-documented procedural distress arising from colposcopy
(Posner and Vessey, 1988; Marteau et al, 1990). It might be
expected that psychosocial effects may differ according to the
severity of the smear abnormality, and the management strategy
adopted. Few studies of the effects of abnormal smear results have
included low-grade abnormalities. Moreover, the available studies
have been limited in terms of size, by a lack of distinction between
different grades of abnormality, or by confounding by manage-
ment/follow-up (Bell et al, 1995; Maissi et al, 2004). Thus, the
factors associated with adverse psychosocial sequelae among
women with low-grade abnormal smears have not been well
elucidated.
This paper focuses on the psychological and psychosocial effects
associated with receipt of a low-grade abnormal smear test result.
Over 3500 women participated in the study, all of whom were
recruited into the TOMBOLA trial (Trial Of Management of
Borderline and Other Low-grade Abnormal smears), a pragmatic
randomised controlled trial of management policies for women
with low-grade abnormal smears (Sharp, 2002). The aims of the
study were to: (1) quantify the levels of anxiety and depression
associated with having received a low-grade abnormal smear
result, (2) identify factors associated with increased levels of
anxiety, and (3) identify whether the psychosocial impact of the
abnormal smear result is higher in particular subgroups of women
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s(for example, defined by age, smear result grade and prior history
of another low-grade abnormal smear).
MATERIALS AND METHODS
Subjects
A total of 3731 TOMBOLA participants recruited between February
2001 and January 2003 took part in the detailed psychosocial
evaluations. Eligible women were aged 20–59 years, had had a
smear (termed the index smear) taken routinely as part of the NHS
CSPs that showed a low-grade abnormality (either mild dyskar-
yosis or BNA), had no more than one BNA smear in the previous
three years, and were resident in the Grampian Health Board area,
Tayside Health Board area or in the Nottingham area. Women
were ineligible if they were pregnant at the time of recruitment
or had had previous destructive or excisional treatment for
proven or suspected cervical lesions. Recruitment to TOMBOLA
consisted of sending an information leaflet together with an
appointment to attend a hospital-based recruitment clinic to
eligible women. Women eligible for psychosocial evaluations, who
had provided informed consent, were asked to complete a socio-
demographic and lifestyle questionnaire and a baseline psychoso-
cial assessment.
Materials/measures
The socio-demographic and lifestyle questionnaire collected
information including ethnic group, marital status, education
since leaving school, employment status, pregnancy and child-
birth, smoking habits and physical activity. Information on time
from index smear to recruitment was obtained from the trial
database. The baseline psychosocial booklet included the Hospital
Anxiety and Depression Scale (HADS) (Zigmond and Snaith,
1983), the Multi-dimensional Health Locus of Control Scale
(MHLCS) (Wallston et al, 1978) and a questionnaire designed
specifically for use within TOMBOLA, the Process Outcome
Specific Measure (POSM) (Gray et al, 2005).
The HADS is a well-validated instrument used to screen for
clinically significant depression and anxiety. It is a self-report
inventory that consists of 14 items on two subscales, seven items
measuring anxiety and seven measuring depression. Each item is
scored on a four-point scale from 0 to 3. The items are summed
yielding two subscale scores each ranging from 0 to 21. Following
established practice, we categorised women’s scores to indicate
‘non-cases’ (scores 0–7), ‘possible cases’ (scores 8–10) and
‘probable cases’ (scores of 11 or more) (Fayers and Machin,
2000). Most women (n¼3530) completed all of the questions on
the HADS. For those who had completed at least 50% of either the
anxiety or depression subscales (n¼35 (o1%); n¼31 (o1%),
respectively), best subset regression (StataCorp, 2003) was used to
impute scores. The remaining women were excluded from the
analyses.
The MHLCS measures three dimensions of health locus of
control: ‘internality’; ‘chance externality’; and ‘powerful others
externality’ (Wallston et al, 1978). The scale consists of three six-
item subscales, scored using a six-point forced choice response
scale, which ranges from 1 ‘strongly disagree’ to 6 ‘strongly agree’.
Possible scores on each subscale range from 6 to 36. As
recommended by the MHLCS authors, a score was calculated for
respondents who had completed at least four out of six questions
for each subscale (Wallston, 2004). For the internal subscale 109
(3%) women had scores imputed. For the powerful others subscale
152 (4%) women had scores imputed and for the chance subscale
170 (5%) women had scores imputed. Women who failed to
complete at least four questions on a subscale were excluded from
the analysis: n¼79 (2%) for the internal subscale, n¼80 (2%) for
the powerful others subscale, and n¼91 (3%) for the chance
subscale.
The POSM consists of 16 questions, 11 of which are framed in
the form of forced choice personalised statements using a six-point
Likert style response format ranging from ‘strongly agree’ to
‘strongly disagree’, and two that relate to change and include
a no change response option (Gray et al, 2005). There are two
filter questions, which allow respondents to skip questions not
applicable to them. There is one question that asks about
perceived risk of developing cervical cancer in the future. The
POSM was included in the analysis to help identify factors likely
to be particularly relevant to the management of low-grade
abnormalities, which may be associated with raised levels
of anxiety. Levels of missing data did not exceed 4% for any
one question.
Analysis
Univariate analysis using the w
2-test was used to investigate
associations between anxiety and socio-demographic factors,
depression, POSM and MHLCS. Owing to the very small
proportion of women scoring X11 on the HADS depression
subscale, all scores of 8 or more on this subscale were combined
into one category (possible and probable cases combined). The
MHLCS subscale scores were divided into tertiles. The responses to
the POSM were combined to produce either a dichotomous
outcome (i.e. agree/disagree) or three-point response outcomes
(e.g. change for the better/no change/change for the worse).
Factors associated with anxiety were investigated using multiple
logistic regression to compute odds ratios (OR) using STATA 8.0
(StataCorp, 2003). The binary outcome variable was o8 and X8.
This categorisation was chosen because (1) the aim of interven-
tions to minimise or reduce anxiety would be to render subjects
‘non-cases’ (i.e. to have a score of less than 8 on the anxiety
subscale), and (2) the three-point categorisation would not have
permitted stable estimates to be obtained from the multivariate
analysis. A range of socio-demographic and lifestyle factors, the
HADS depression subscale, the three dimensions of the MHLCS
and all of the 14 informative questions of the POSM were
considered as potential explanatory variables. A multivariate
model was developed using a nested approach; if the P-value for
the likelihood ratio test of the change in deviance ( 2 log
likelihood) between a model containing a particular variable, and a
model not containing this variable, was less than 0.1, the variable
was retained in the model. The goodness-of-fit of each model was
checked using the Hosmer & Lemeshow test (Hosmer and
Lemeshow, 1989) and the final model reported fits the data
adequately (P¼0.666).
RESULTS
Of the 3731 women who attended a recruitment appointment and
consented to participate in the TOMBOLA psychosocial study,
3671 (98%) completed both a socio-demographic and psychosocial
questionnaire.
The mean age of participants was 34 (standard deviation
(s.d.)¼10.6 years). Forty-two per cent of women were in the 20–
29 year age group (Table 1). Twent-four per cent were recruited on
the basis of a mild smear and 76% on the basis of a BNA smear. 5%
of women had had a BNA smear in the three years before the index
smear: 24 of these women had a mild index smear and 155 a smear
showing BNA. The median time from index smear to recruitment
(and hence completion of the questionnaires) was 71 days. Ninety-
six per cent of women described their ethnic group as white.
Slightly more than half were married or living as married (56%)
and half were in full-time employment (50%). Slightly more
women had been to college/university (54%) than had not (47%).
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35% that they were current smokers and 17% that they were ex-
smokers.
Over half of the women (57%) were classed as being a non-case
(scored o8 on the HADS anxiety subscale). A fifth of women had
scores consistent with being possible cases (scored 8–10) and
almost a quarter (23%) had scores that indicated a probable
clinically significant level of anxiety (scored X11). The vast
majority of women (91%) were classed as non-cases on the HADS
depression subscale (scored o8). The mean MHLCS score for the
internal subscale was 26 (s.d. 4.3). For the powerful others subscale
the mean score was 17 (s.d. 5.9) and for the chance subscale the
mean score was 19 (s.d. 5.3).
In univariate analyses, statistically significant associations were
found between anxiety and age, trial centre, marital status,
employment status, training, physical activity, ever having had a
child, and smoking status (Table 2). The associations with age,
physical activity, ever having had a child and smoking status
remained in the multivariate analysis. A lower proportion of older
women (aged 50–59) scored 8–10 or X11 on the HADS anxiety
subscale than women in other age groups (w
2¼16.89, P¼0.010).
When those scoring X8 on the HADS anxiety subscale were
combined, the multivariate OR for the 50–59 vs the 20–29 age
groups was statistically significantly less than unity (OR¼0.68,
95% confidence interval (CI)¼0.48–0.97). Women exercising 43
times per week were more likely to be classed as probable cases
(26%) or possible cases (22%) than women who took exercise less
than once per week or took no exercise (22% probable cases and
19% possible cases). The multivariate risk estimate for the most
active group vs the least active was statistically significantly raised
(OR¼1.52, 95% CI¼1.26–1.85). Women who had had children
were significantly more likely to be anxious than women who
never had children (OR¼1.26, 95% CI¼1.03–1.55). This was
accounted for by an increased proportion scoring X11 among
those having had children. 29% of current smokers were classified
as probable cases compared to 22% of ex-smokers and 19% of
never smokers. The OR for current smokers was significantly
higher than unity (OR¼1.52, 95% CI¼1.26–1.84). There was little
evidence of an association between anxiety and either index smear
status or previous history of a BNA smear (Table 2). The time
between a woman’s index smear test and date of completion of the
psychosocial questionnaire (recruitment date) was not related to
HADS anxiety score (data not shown).
There was a very strong association between the HADS anxiety
and the HADS depression scores. Ninety-five per cent of women
who scored X8 on the depression subscale also scored X8 on the
anxiety subscale (Table 3). The strength of the association was
reflected in the OR of 29.14 (95% CI¼16.22–52.37). In the
univariate analyses, there were significant associations between all
three locus of control subscales and anxiety status. However, the
association with the chance subscale did not persist in the
multivariate analysis. Risk of anxiety decreased with increasing
score on the internal subscale (P for trend¼0.008).
In the univariate analysis there were statistically significant
associations between anxiety and all but three of the POSM
questions – these questions related to (1) whether the information
received answered concerns about the smear result (question 2),
(2) future cervical screening intentions (question 13), and (3)
belief about regular screening reducing the risk for cervical
cancer (question 14). In the multivariate analysis, there were
significant associations between anxiety and worries about
general health, feelings about self, worries about cervical cancer,
future fertility, sex life, perceived risk of cervical cancer and
support. Cases of anxiety were more common among women
who felt worse about themselves since receiving their smear
result (OR¼2.07, 95% CI¼1.70–2.53). There were very strong
positive relations between anxiety and worries that the next
smear would show changes to the cells, worries about having
cervical cancer, worries about future fertility and worries
about having sex. Fifty per cent of women reporting that their
sex life had changed for the worse were probable cases compared
to 19% reporting no change and 25% reporting change for
the better.
Table 1 Socio-demographic characteristics of respondents participating
in the baseline psychological assessment within TOMBOLA
n %
Age group
20–29 years 1551 42
30–39 years 982 27
40–49 years 797 22
50–59 years 341 9
Index smear status
Mild 882 24
BNA 2789 76
Previous smear history in the 3 years before index smear
No abnormal smear 3492 95
One BNA 179 5
Trial centre
A 1207 33
B 882 24
C 1582 43
Ethnic group
White 3515 96
Non-white 148 4
Missing 8 —
Marital status
Married/living as married 2042 56
Divorced/separated/widowed 492 14
Single 1107 30
Missing 30 —
Employment status
Full-time paid employment 1819 50
Part-time paid employment 864 24
Student 340 9
Not in paid employment 645 18
Missing 3 —
Training
None 990 27
Through work with qualification 725 20
Qualification other than degree from college/university 1046 29
Degree from college/university 901 25
Missing 9 —
Physical activity
oOnce/week 1456 40
1–3 times/week 867 24
43 times/week 1310 36
Missing 38 —
Ever had children
Yes 2048 56
No 1591 44
Missing 32 —
Smoking status
Never smoker 1760 48
Ex-smoker 627 17
Current smoker 1260 35
Missing 24 —
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sTable 2 Associations between the HADS anxiety subscale and socio-demographic and lifestyle factors
Hospital Anxiety and Depression Scale – anxiety subscale
Non-case (o8)
(n¼2033)
Doubtful case (8–10)
(n¼711)
Probable case (410)
(n¼818) Multivariate analysis
a
n % n % n %O R
b (95% CI)
Age group
20–29 years 850 57 308 21 341 23 1.00 (ref)
30–39 years 516 54 189 20 253 26 0.97 0.78–1.22
40–49 years 456 59 154 20 169 22 0.85 0.66–1.10
50–59 years 211 65 60 18 55 17 0.68 0.48–0.97
P-value from w
2-test 0.010
P-value from w
2-test for trend 0.031
Global P-value 0.133
Index smear status
Mild 477 56 161 19 213 25 1.00 (ref)
BNA 1556 57 550 20 605 22 1.09 0.90–1.32
P-value from w
2-test 0.236
Global P-value 0.397
Previous smear history in the 3 years before index smear
No abnormal smear 1930 57 675 20 782 23 1.00 (ref)
One BNA 103 59 36 21 36 21 0.93 0.64–1.37
P-value from w
2-test 0.742
Global P-value 0.722
Median time from index smear to recruitment
(days)
72 70 70
Trial centre
A 707 61 237 20 214 18 1.00 (ref)
B 470 54 169 19 231 27 1.06 0.85–1.33
C 856 56 305 20 373 24 0.95 0.79–1.16
P-value from w
2-test o0.001
Global P-value from LR test 0.595
Ethnic group
White 1955 57 671 20 788 23 1.00 (ref)
Non-white 78 56 35 25 27 19 0.80 0.51–1.25
P-value from w
2-test 0.242
Global P-value from LR test 0.324
Marital status
Married/living as married 1155 58 368 19 464 23 1.00 (ref)
Divorced/separated/widowed 251 53 99 21 124 26 0.98 0.76–1.28
Single 610 57 240 22 222 21 0.90 0.71–1.13
P-value from w
2-test 0.019
Global P-value from LR test 0.638
Employment status
Full-time paid employment 1075 60 349 20 355 20 1.00 (ref)
Part-time paid employment 483 57 172 20 186 22 0.97 0.77–1.21
Student 175 55 72 23 72 23 1.04 0.77–1.40
Not in paid employment 298 48 118 19 204 33 1.02 0.79–1.33
P-value from w
2-test o0.001
Global P-value from LR test 0.970
Training
None 522 54 180 19 258 27 1.00 (ref)
Through work with qualification 378 54 150 21 176 25 1.14 0.89–1.45
Qualification other than degree from college/
university
616 60 190 19 214 21 0.84 0.67–1.06
Degree from college/university 512 59 190 22 167 19 0.97 0.75–1.25
P-value from w
2-test 0.001
Global P-value from LR test 0.096
Physical activity
oOnce/week 838 60 263 19 304 22 1.00 (ref)
1–3 times/week 509 60 159 19 181 21 1.13 0.91–1.40
43 times/week 663 52 283 22 324 26 1.52 1.26–1.85
P-value from w
2-test 0.001
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sDISCUSSION
We found that 23% of women who had recently received a low-
grade abnormal cervical smear test result scored X11 on the
anxiety subscale of the HADS, and a further 20% scored between 8
and 10. The frequency scoring X11 was substantially higher than
that observed in women in a non-clinical general adult UK
population (16%) (Crawford et al, 2001). Moreover, our findings
are consistent with those from a study of women who had received
higher-grade abnormal cervical smear results (Bell et al, 1995).
Age was inversely associated with anxiety in our final model
(P¼0.031), although the risk estimate was only statistically
significant for women in the oldest age group (50–59 years). It
may be that older women had fewer worries about issues such as
future fertility and their sex lives and thus, were not as concerned
by the smear result. Screening uptake in the UK exceeds 80% (NHS
CSP, 2004; ISD Scotland, 2005) and the frequency of low-grade
abnormal smears is highest in women under 30 and declines with
age (10.5% of smears in this age group, compared to 5.7, 4.7 and
2.8% in the 30–39, 40–49 and 50–59 age groups, respectively)
(NHS Health and Social Care Information Centre, 2005). The
implication of our results is that considerable numbers of younger
women could be experiencing adverse psychosocial consequences
of screening. At the time participants were recruited to the study,
the NHS CSPs in England and Scotland screened women aged 20–
59 (Scotland) or 64 (England). Since then, and in response to
analyses suggesting that smears are not as effective in younger
women (Sasieni et al, 2003), the programme in England has raised
the lower screening limit to 25 (http://www.cancerscreening.nh-
s.uk/cervical). This age limit is consistent with programmes in
countries including Norway, Italy, France and Belgium, although is
still younger than the lower age limit in some other countries (e.g.
Finland, Sweden, Netherlands) (IARC Working Group, 2005). It
might be suggested that the levels of anxiety experienced by
younger women with low-grade smears provides a further
argument for excluding these women from screening. It is
noteworthy, however, that in our analysis the risk of having a
HADS anxiety score of X8 was essentially the same in women aged
30–39 as those aged 20–29 (multivariate OR 30–39 vs 20–
29¼0.97). Moreover, 26% of the 30–39 age group were classified
as definite cases (score X11) compared to 23% of the 20–29 age
group. Thus, our observation of an inverse association between age
and anxiety is not simply a consequence of higher levels in the
youngest women; there are considerable levels of anxiety in women
aged 30–39 and this needs to be addressed.
A mild smear corresponds to a higher grade of abnormality than
a BNA smear; however, there was no relation between smear status
and HADS anxiety score. There are at least two possible
explanations for this. First, before their TOMBOLA recruitment
appointment, women may not have been told explicitly what their
smear result was. We are aware that women may not be told the
grade of their smear result, but simply that it is abnormal. This is
supported by a study from a single health authority (Nottingham),
which showed that there was considerable variation in both the
method and content of communications delivering mild and BNA
smear results (Philips et al, 2002). Second, women may have been
told the grade of the smear but may not have understood its
clinical significance. For example, a BNA smear may have been
interpreted as being ‘borderline cancer’ rather than ‘borderline
normal’. It appears that women often do not understand the
purpose and indications of the cervical smear (Fylan, 1998), or
the meaning of pre-cancer, and erroneously conclude that
any abnormalities detected by screening must indicate cancer
(Kavanagh and Broom, 1997). As our results indicate that there are
similar levels of anxiety overall among women with low-grade
smears as among women with high-grade smears, it seems likely
that it is the receipt of an abnormal smear result per se, irrespective
of the grade, which engenders adverse psychosocial consequences.
We anticipated that women who had had a BNA smear result in the
three years before their index smear would be more anxious than
women who had not previously had an abnormal smear. However,
there was no relationship between prior BNA smear and anxiety.
In part this may have been due to the relatively small numbers of
women in our study who had had a prior BNA smear (n¼175, 5%
overall). Alternatively, it is possible that receipt of an abnormal
smear causes a spike in anxiety that resolves over time, thus a
smear taken up to 3 years ago might not impact on current anxiety
levels. A recent study showed that whereas informing women that
they had an abnormal smear (with or without HPV testing) was
associated with raised levels of state anxiety and general distress in
Table 2 (Continued)
Hospital Anxiety and Depression Scale – anxiety subscale
Non-case (o8)
(n¼2033)
Doubtful case (8–10)
(n¼711)
Probable case (410)
(n¼818) Multivariate analysis
a
n % n % n %O R
b (95% CI)
P-value from w
2-test for trend o0.001
Global P-value from LR test o0.001
Ever had children
No 931 60 307 20 311 20 1.00 (ref)
Yes 1085 55 401 20 497 25 1.26 1.03–1.55
P-value from w
2-test 0.001
Global P-value from LR test 0.025
Smoking status
Never smoker 1070 63 320 19 319 19 1.00 (ref)
Ex-smoker 350 58 123 20 132 22 1.22 0.97–1.54
Current smoker 603 49 262 21 360 29 1.52 1.26–1.84
P-value from w
2-test o0.001
Global P-value from LR test o0.001
aOutcome either 0¼non-cases (o8) or 1¼definite or doubtful cases (¼48).
bMutually adjusted for: ever had children, training, smoking status, physical activity, age,
depression, internal subscale, powerful others subscale, POSM q3–6, q10, q11, q15, q16. 139 women did not complete a sufficient number of questions on one or more of the
outcome measures and were excluded from the analysis. Bold values indicate statistically significant results.
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sTable 3 Associations between the HADS anxiety subscale and the HADS depression subscale status, baseline MHLCS status and POSM responses
Hospital Anxiety and Depression Scale – anxiety subscale
Non-case (o8) (n¼2033) Possible case (8–10) (n¼711) Case (410) (n¼818) Multivariate analysis
a
n % n % n %O R
b (95% CI)
Depression subscale
Non-case (o8) 2017 62 659 20 566 17 1.00 (ref)
Doubtful/probable case (8 or more) 15 5 51 16 251 79 29.14 16.22–52.37
P-value from w
2-test o0.001
Global P-value from LR test o0.001
MHLCS internal (tertiles)
Low 580 53 225 20 294 27 1.00 (ref)
Medium 592 58 203 20 221 22 0.87 0.70–1.07
High 834 59 278 20 295 21 0.76 0.63–0.93
P-value from w
2-test 0.004
P-value from w
2-test for trend 0.008
Global P-value from LR test 0.030
MHLCS chance (tertiles)
Low 697 62 195 17 234 21 1.00 (ref)
Medium 557 58 196 20 213 22 0.99 0.80–1.23
High 744 52 315 22 360 25 1.08 0.88–1.33
P-value from w
2-test o0.001
P-value from w
2-test for trend 0.430
Global P-value from LR test 0.627
MHLCS powerful others (tertiles)
Low 668 65 178 17 178 17 1.00 (ref)
Medium 719 60 203 17 267 22 0.96 0.78–1.19
High 618 47 325 25 365 28 1.55 1.26–1.91
P-value from w
2-test o0.001
P-value from w
2-test for trend o0.001
Global P-value from LR test o0.001
POSM questions
1 In general I feel well enough informed about what my smear result means.
Agree 1835 58 630 20 702 22 1.00 (ref)
Disagree 184 50 74 20 112 30 1.22 0.93–1.60
P-value from w
2-test 0.001
Global P-value from LR test 0.151
2 The information I have received has answered the concerns I have had about my smear result.
Agree 1845 57 649 20 731 23 1.00 (ref)
Disagree 113 50 47 21 65 29 1.24 0.89–1.73
P-value from w
2-test 0.067
Global P-value from LR test 0.208
3 Since getting my smear result I have been worried about my general health.
Disagree 820 77 126 12 118 11 1.00 (ref)
Agree 1196 48 577 23 697 28 1.83 1.47–2.28
P-value from w
2-test o0.001
Global P-value from LR test o0.001
4 Since getting my smear result the way I feel about myself has changed.
Neither better nor worse 1547 67 388 17 370 16 1.00 (ref)
For the better 140 43 80 25 105 32 1.82 1.37–2.43
For the worse 322 36 231 26 335 38 2.07 1.70–2.53
P-value from w
2-test o0.001
Global P-value from LR test o0.001
5 Since getting my smear result I have been worried that my next smear will show changes to the cells.
Disagree 307 80 46 12 29 8 1.00 (ref)
Agree 1707 54 658 21 783 25 1.48 1.03–2.12
P-value from w
2-test o0.001
Global P-value from LR test 0.031
6 Since getting my smear result I have been worried that I may have cervical cancer.
Disagree 846 75 167 15 121 11 1.00 (ref)
Agree 1165 49 536 22 691 29 1.50 1.22–1.85
P-value from w
2-test o0.001
Global P-value from LR test o0.001
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evident 6 months later (Maissi et al, 2005).
Elucidation of factors associated with raised levels of anxiety is
likely to be helpful in identifying: (1) particularly vulnerable
subgroups of the population, (2) particular issues that may be
causing concern or worries among women, and (3) targets that
could be addressed in interventions aimed at helping alleviate
anxiety. Having had children was a significant predictor of scoring
X8 on the HADS anxiety subscale. Previous studies have shown
that there are higher rates of psychiatric disorders in women with
children, although the authors of these studies have suggested that
the difference is due to an effect of marriage rather than parity
(Dean and White, 1996). In our study, marital status was
significantly associated with having had children; over 70% of
women who were married/living as married (or who had
previously been married) had had children compared to only
19% of single women. Marital status, however, was not associated
with anxiety in our multivariate model.
Table 3 (Continued)
Hospital Anxiety and Depression Scale – anxiety subscale
Non-case (o8) (n¼2033) Possible case (8–10) (n¼711) Case (410) (n¼818) Multivariate analysis
a
n % n % n %O R
b (95% CI)
8 Since getting my smear result I have been worried about my ability to have children in the future.
c
Disagree 359 71 84 17 66 13 1.00 (ref)
Agree 362 46 183 23 246 31 1.61 1.19–2.18
P-value from w
2-test o0.001
Global P-value from LR test 0.002
9 Because of the follow-up for my smear I have decided to delay getting pregnant.
c
Disagree 313 61 104 20 94 18 1.00 (ref)
Agree 85 39 49 23 83 38 1.41 0.94–2.12
P-value from w
2-test o0.001
Global P-value from LR test 0.101
10 Since getting my smear result I have been worried about having sex.
Disagree 1623 65 463 18 429 17 1.00 (ref)
Agree 348 37 227 24 366 39 1.75 1.44–2.11
P-value from w
2-test o0.001
Global P-value from LR test o0.001
12 Since getting my smear result my sex life has changed.
d
Neither better nor worse 1628 62 500 19 504 19 1.00 (ref)
For the better 29 43 21 31 17 25 1.38 0.76–2.53
For the worse 78 28 61 22 141 50 1.50 1.06–2.13
P-value from w
2-test o0.001
Global P-value from LR test 0.046
13 I intend to continue having regular smears.
Agree 1998 57 704 20 809 23 1.00 (ref)
Disagree 8 73 1 9 2 18 1.28 0.31–5.26
P-value from w
2-test 0.535
Global P-value from LR test 0.733
14 I believe that having regular smears reduces my risk of getting cervical cancer.
Agree 1896 57 680 20 775 23 1.00 (ref)
Disagree 72 62 20 17 25 21 0.86 0.54–1.37
P-value from w
2-test 0.545
Global P-value from LR test 0.516
15 What do think your chances are of developing cervical cancer in the future?
Average 1520 60 478 19 526 21 1.00 (ref)
Lower than average 210 61 69 20 63 18 0.99 0.74–1.34
Higher than average 262 41 154 24 217 34 1.71 1.38–2.12
P-value from w
2-test o0.001
Global P-value from LR test o0.001
16 Since getting my smear result I have generally been satisfied with the support I have had from other people.
Agree 1827 58 638 20 705 22 1.00 (ref)
Disagree 130 44 61 21 103 35 1.56 1.15–2.11
P-value from w
2-test o0.001
Global P-value from LR test 0.004
aOutcome either 0¼non cases (o8) or 1¼definite or doubtful cases (¼48)
bMutually adjusted for: ever had children, training, smoking status, physical activity, age,
depression, internal subscale, powerful others subscale, POSM q3–6, q10, q11, q15, q16. 139 women did not complete a sufficient number of questions on one or more of the
outcome measures and were excluded from the analysis.
cIn women who did not answer ‘no’ to POSM q7 (Before you received your smear result were you planning to have a
child in the future?).
dIn women who did not answer ‘no’ to POSM q11 (Are you sexually active?). Bold values indicate statistically significant results.
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sWomen who reported themselves to be current smokers were
significantly more likely to be anxious than women who had never
smoked. Other studies have found an association between smoking
and increased anxiety, and poor psychological health has been
shown to increase cigarette consumption (Graham and Der, 1999;
Bonnet et al, 2005). One possible explanation for our finding could
be that smokers believe that smoking raises their cervical cancer
risk. In our study, women who thought that their chances of
getting cancer were higher than average were at increased risk of
being anxious and smoking status was significantly associated with
belief about chance of getting cancer. Twenty per cent of current
smokers believed their chance was higher than average, 74% that it
was average and 7% that it was less than average; the comparable
figures for never smokers were 18, 71 and 12%.
We found that women who were most physically active were
significantly more likely to score X8 on the HADS anxiety
subscale. An explanation for this intriguing finding is not obvious,
and we might have expected the opposite relation given the
positive effects of exercise on endorphins, and hence on mental
health generally (Daley, 2002). Although the difficulties in accurate
assessment of physical activity levels in epidemiological studies are
well known (IARC Working Group, 2002), there is no evidence that
reporting varies by level of anxiety. It is possible that women who
engage in the highest levels of physical activity are also the most
health conscious and, as a result, are most anxious when they
receive an abnormal smear result.
Women who were worried about their general health, that their
next smear would be abnormal or about having cervical cancer
were all at a significantly increased risk of being anxious compared
to women who were not worried about these issues. This is
consistent with other studies in which receipt of an abnormal
smear is associated with women’s fears that they have cancer
(Doherty et al, 1991; Lerman et al, 1991; Somerset and Peters,
1998). Women who perceived their chances of developing cervical
cancer in the future to be higher than average were at a
significantly increased risk of being anxious than women who
perceived their chances as average or below average. This is
congruent with a recent study of women who had received
inadequate smear results among whom perceived risk was found to
be a risk factor for state anxiety (French et al, 2004). In the current
study, anxiety was significantly higher in women who were worried
about their ability to have children in the future and in those who
had decided to delay getting pregnant. Previous studies have
confirmed that women who have had an abnormal smear are
concerned about their future fertility and that this may be related
to fear about what further treatment might be involved (McDonald
et al, 1989; Quilliam, 1990).
Two of the POSM questions asked about change in self-
perception and change in sex life since receipt of the smear test
result. Interestingly, women who indicated any change, whether
for the better or for the worse, were more likely to be anxious than
women who responded that there had been no change. It may be
that the change (for better or for worse) resulted from increased
anxiety caused by the abnormal smear result.
Although most of the responses to the POSM questions were
associated with anxiety in multivariate analyses, five were not. Two
of these questions related to intention to continue having regular
smears and belief that regular smears reduce risk of developing
cervical cancer. For both of these questions, only small propor-
tions of women (o1 and 3%, respectively) disagreed with the
statements. It might have been expected, given the reasonably high
overall levels of anxiety in the study population, that women might
have felt somehow dissatisfied with the information they had
received about their smear result. In contrast, over 90% of women
felt well informed about what their smear result meant and 92%
were satisfied that the information received had addressed any
concerns. This apparent contradiction may suggest that the
information that women receive (or source for themselves), and/
or the way in which the information is conveyed, is not providing
adequate reassurance. Previous research has shown that the way in
which smear results are conveyed and the content of the
communication varies, not only across, but also within health
authorities (Philips et al, 2002). Moreover, there is no guarantee
that women will understand the information contained in the
communication of the smear result. Further study of what
information women receive and how different methods of
communicating results to women influence levels of anxiety would
be useful.
We observed a significant inverse relationship between internal
locus of control and anxiety and, compatible with this, women who
scored highly on the powerful others externality subscale were at
increased risk of anxiety. Other studies have found that an external
locus of control is significantly associated with anxiety disorders
and that women who score highly on the internal subscale are
more likely to report good health (Raja et al, 1994; Beekman et al,
2000). In relation to communication and information provision, a
recent study found that matching health messages to an
individual’s health locus of control in women resulted in higher
attendance for a mammogram (Williams-Piehota et al, 2004). It
may be possible to assess locus of control in the context of cervical
screening and to present information that is targeted to match the
individual’s locus of control, for example, when women access
web-based health information.
We assessed anxiety using the HADS, a screening (rather than
diagnostic) test for clinically significant anxiety (and depression)
which is widely used in both clinical and non-clinical settings
(Crawford et al, 2001; Strik et al, 2004). Although we were not in a
position to cross validate the HADS cut-offs for possible and
probable cases with a standardised diagnostic interview, in pilot
testing the HADS proved reliable in women recruited to
TOMBOLA (Gray et al, 2005). In terms of classifying respondents,
investigators have used a variety of schemes, including cut-offs at 8
(Osborne et al, 2003) and 11 (Pascoe et al, 2000). We decided to
take a score of X8 as indicating a level of anxiety that could be
considered abnormal and, therefore, may warrant intervention.
The main reason for choosing 8 as a cut-off was that we wanted to
ensure that any suggested interventions arising from the analyses
would be relevant to the greatest number of women (i.e. not just to
women scoring above 10). The aim of such interventions would be
to render the maximum number of women ‘non-cases’ (i.e. to have
a score of less than 8 on the anxiety subscale); thus, it would not be
sufficient to move women who were probable cases to possible
cases. A secondary consideration was that we wanted the estimates
from our multivariate analyses to be stable making sure that we
had an adequate number of subjects in each analysis cell/
subgroup: using a cut-off of 8, rather than 11, helped to ensure
this. We undertook a sensitivity analysis to determine whether our
results were dependent on the chosen cut-point. The analysis was
repeated using a score of 11 or more to identify ‘cases’ with those
scoring 10 or less classified as ‘non-cases’. The results were
essentially unchanged; the only substantive difference was that
level of post-school education entered the model as a significant
predictor of anxiety.
Strengths and limitations of the study
Our study is one of the very few to have focussed only on women
with low-grade abnormal smears. As far as we are aware, it is the
largest study of the psychological status of women with such
abnormalities and, including more than 3500 women, it is one of
the largest studies of the determinants of anxiety to have been
reported.
Participants were recruited from the cervical screening pro-
grammes in Scotland and England and are likely to be
representative of the UK screening population as a whole. The
three study centres comprise both rural and city-based popula-
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stions and incorporate affluent and deprived areas and the centre in
England was ethnically diverse. Ninety-eight per cent of women
asked to complete the psychosocial questionnaires did so.
Furthermore, we measured anxiety prior to women knowing how
they would be followed-up so there is no contamination of the
results with any effects of treatment. Women in TOMBOLA are
being followed for 3 years, over which time they will complete
psychosocial questionnaires at four time points. This will permit
temporal trends in anxiety to be charted.
Women were asked to complete the questionnaires at a
recruitment appointment in a hospital-based clinic setting and it
is possible that attending the appointment contributed to anxiety.
Maissi et al, 2004 found that whether an abnormal smear is a
woman’s first smear may be a predictor of concern about the test
result. Our access to a woman’s smear history before her
participation in TOMBOLA was restricted. Therefore, we could
not identify whether the abnormal smear that made a woman
eligible for inclusion in TOMBOLA was her first cervical smear.
However, the lack of a substantial difference in anxiety between
women aged 20–29 and women aged 30–39 suggests that our
results are not driven by the effect of first smears. Twenty-one per
cent of women aged 20–29 scored between 8 and 10 compared to
20% of women aged 30–39; furthermore, 23% of women aged
20–29 scored X11 compared to 26% of women aged 30–39.
Although standardised trial information leaflets were given to all
participants, women received their smear results in the usual way
and this differed between and within centres. We also had no
control over the information women received from other health
professionals or sourced for themselves. This undoubtedly led to
variation in the amount and quality of information women
received and also in the means of communication.
Implications and conclusions
Assessing the levels and determinants of psychological and
psychosocial consequences of receiving a low-grade abnormal
smear result is of considerable public health importance. As low-
grade smears account for the majority of cervical smears classed as
abnormal in the UK, the results of our study suggest that
significant numbers of women could be incurring adverse
psychological and psychosocial consequences of screening. We
have found a high prevalence of anxiety among women who have a
low-grade smear, and that the proportion scoring in the abnormal
range is consistent with previous studies of women with high-
grade smear results. We further found that those who are at
highest risk of anxiety tend to be younger, have children, be
current smokers, or have higher levels of physical activity. These
may represent particularly vulnerable subgroups of the screening
population. We will further investigate the determinants of anxiety
in the analysis of the TOMBOLA longitudinal data. Strategies are
needed to minimise the adverse effects of a low-grade smear result
on women. Interventions that focus particularly on women’s
understanding of smear results and pre-cancer, and those that
directly address their fears about cancer, treatment and fertility
might provide greatest opportunity to reduce the adverse
psychosocial impact of receiving a low-grade abnormal cervical
smear result.
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